Cargando…

The role of gut microbiota metabolite trimethylamine N-oxide in functional impairment of bone marrow mesenchymal stem cells in osteoporosis disease

BACKGROUND: Osteoporosis (OP) is a prevalent metabolic bone disease characterized by bone loss and structural deterioration, which increases the risk of fracture especially in older people. Recent research has shown that gut microbes play an important role in OP. Trimethylamine N-oxide (TMAO), a gut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hao, Liu, Tianfeng, Li, Xiao, Gao, Xiang, Wu, Tingrui, Li, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475507/ https://www.ncbi.nlm.nih.gov/pubmed/32953809 http://dx.doi.org/10.21037/atm-20-5307

Ejemplares similares

The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2018)

Elevation of the Gut Microbiota Metabolite Trimethylamine N-Oxide Predicts Stroke Outcome
por: Nam, Hyo Suk, et al.
Publicado: (2019)

Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke
por: Sun, Taoping, et al.
Publicado: (2021)

Gut microbiota in atherosclerosis: focus on trimethylamine N‐oxide
por: Zhu, Yingqian, et al.
Publicado: (2020)

The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases
por: Zhen, Jing, et al.
Publicado: (2023)

Metabolic retroconversion of trimethylamine N-oxide and the gut microbiota
por: Hoyles, Lesley, et al.
Publicado: (2018)

Gut microbiota dependant trimethylamine N-oxide and hypertension
por: Mutengo, Katongo H., et al.
Publicado: (2023)

Gut microbiota-derived metabolite trimethylamine-N-oxide and stroke outcome: a systematic review
por: Zhang, Peng, et al.
Publicado: (2023)

Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide
por: Nam, Hyo Suk
Publicado: (2019)

Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation
por: Kim, Seok-Jo, et al.
Publicado: (2022)

Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
por: Wang, BingYu, et al.
Publicado: (2021)

High-circulating gut microbiota-dependent metabolite trimethylamine N-oxide is associated with poor prognosis in pulmonary arterial hypertension
por: Yang, Yicheng, et al.
Publicado: (2022)

Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide Contributes to Cardiac Dysfunction in Western Diet-Induced Obese Mice
por: Chen, Kui, et al.
Publicado: (2017)

Gut microbiota–derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis
por: Li, Doudou, et al.
Publicado: (2022)

Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease
por: He, Wei, et al.
Publicado: (2020)

The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid
por: Rio, Daniele Del, et al.
Publicado: (2017)

Trimethylamine N-Oxide, a Gut Microbiota-Dependent Metabolite, is Associated with Frailty in Older Adults with Cardiovascular Disease [Corrigendum]
Publicado: (2021)

Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand
por: Senthong, Vichai, et al.
Publicado: (2021)

It's a “Gut Feeling”: Association of Microbiota, Trimethylamine N‐Oxide and Cardiovascular Outcomes
por: Kolluru, Gopi K., et al.
Publicado: (2020)

Paradox of trimethylamine-N-oxide, the impact of malnutrition on microbiota-derived metabolites and septic patients
por: Chou, Ruey-Hsing, et al.
Publicado: (2021)

The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis
por: Stec, Albert, et al.
Publicado: (2023)

Gut microbiota dependent trimethylamine N-oxide aggravates angiotensin II–induced hypertension
por: Jiang, Shan, et al.
Publicado: (2021)

Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose–response meta-analysis
por: Farhangi, Mahdieh Abbasalizad, et al.
Publicado: (2020)

Vitamin D Decreases Plasma Trimethylamine-N-oxide Level in Mice by Regulating Gut Microbiota
por: Wang, Xin, et al.
Publicado: (2020)

The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies
por: Huang, Rui, et al.
Publicado: (2021)

Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients
por: Xu, Kai-Yu, et al.
Publicado: (2017)

Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
por: Macpherson, Magnhild E., et al.
Publicado: (2020)

Atherosclerosis amelioration by allicin in raw garlic through gut microbiota and trimethylamine-N-oxide modulation
por: Panyod, Suraphan, et al.
Publicado: (2022)

Rapid Detection of Gut Microbial Metabolite Trimethylamine N-Oxide for Chronic Kidney Disease Prevention
por: Chang, Yu-Chun, et al.
Publicado: (2021)

Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study
por: Sikora, Mariusz, et al.
Publicado: (2021)

Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults
por: Fretts, Amanda M., et al.
Publicado: (2022)

Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-N-Oxide Response in Healthy Men
por: Cho, Clara E., et al.
Publicado: (2020)

Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis
por: Liu, Yarong, et al.
Publicado: (2020)

Trimethylamine N-oxide, a gut microbiota-dependent metabolite of choline, is positively associated with the risk of primary liver cancer: a case-control study
por: Liu, Zhao-Yan, et al.
Publicado: (2018)

Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD)
por: Amrein, Melissa, et al.
Publicado: (2022)

Uncovering the trimethylamine-producing bacteria of the human gut microbiota
por: Rath, Silke, et al.
Publicado: (2017)

Altered gut microbiota and metabolites profile are associated with reduced bone metabolism in ethanol‐induced osteoporosis
por: Liu, Zhao, et al.
Publicado: (2022)

Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome
por: Li, Xingxing, et al.
Publicado: (2021)

Gut Microbiota-Dependent Trimethylamine-N-oxide and Serum Biomarkers in Patients with T2DM and Advanced CKD
por: Al-Obaide, Mohammed A. I., et al.
Publicado: (2017)

Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke
por: Tan, Chuhong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_adqr4od24jciqb0qblp553icr6